“Astromech ($20M, AI genomic analysis)”
“Astromech, a developer of biology-forecasting AI models, raised a $20 million round led by Bob Nelsen at a $3.8 billion valuation.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.
“Astromech... Builds predictive models of biological change trained on 3.8 billion years of evolutionary history”
Source→“On August 19, the day before this interview published, Moderna and Merck reported the first positive Phase 3 for an AI-designed personalized cancer vaccine, sending Moderna shares up 177%, repricing the entire category”
Source→“Astromech, a developer of biology-forecasting AI models, raised a $20 million round led by Bob Nelsen at a $3.8 billion valuation.”
Source→“Astromech builds predictive models of biological change trained on 3.8 billion years of evolutionary history. Applications span cancer, drug resistance, biosecurity, agriculture, and conservation.”
Source→“It's a very focused model, so it doesn't need the breadth that a lot of these other models need. So we don't have to go build a $500 billion data center in computing power”
Source→“It's using AI to build — it's a very focused model. So it doesn't need the breadth that a lot of these other models need... It's looking at evolutionary trends to understand why over evolutionary trends do certain animals have certain conserved regions of the genome that prevent things like cancer.”
Source→“You're going to see this pre-Cambrian explosion of new drugs and new therapies that all come from AI-assisted drug design discovery.”
Source→